These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4550120)

  • 1. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosis.
    Tint GS; Salen G
    J Lipid Res; 1974 May; 15(3):256-62. PubMed ID: 4827915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Bjørkhem I
    Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

  • 9. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
    Buchmann MS; Björkhem I; Lund AM; Skrede S
    Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
    Kuriyama M; Fujiyama J; Kasama T; Osame M
    J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterol synthesis in the human arterial intima.
    Chorbanian AV
    J Clin Invest; 1968 Mar; 47(3):595-603. PubMed ID: 5637146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
    N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
    McKenna P; Morgan SJ; Bosanquet RC; Laker MF
    Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma esterification of cholestanol, normally and in cerebrotendinous xanthomatosis.
    Skrede S; Stokke KT
    Scand J Clin Lab Invest; 1974 Apr; 33(2):97-100. PubMed ID: 4853665
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
    Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
    Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the mechanism of the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis. The activity of delta 5-3 beta-hydroxysteroid dehydrogenase.
    Buchmann MS; Björkhem I; Fausa O; Skrede S
    Scand J Gastroenterol; 1985 Dec; 20(10):1262-6. PubMed ID: 3868019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis: in vivo labeling of cerebral sterols and sterol esters.
    Gardner-Medwin D; Kishimoto Y; Derby BM; Moser HW
    Trans Am Neurol Assoc; 1971; 96():241-4. PubMed ID: 5159092
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcellular distribution of cerebral cholestanol in cerebrotendinous xanthomatosis.
    Stahl WL; Sumi SM; Swanson PD
    J Neurochem; 1971 Mar; 18(3):403-13. PubMed ID: 5559251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.